Delivery Order SPE2DB20D3505-SPE2DB23FT5F2
Award Date 1/9/23
Potential Completion Date 1/10/23
Potential Value $5.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,664.10, is a delivery order for the ROTATEQ vaccine in 2 milliliter vials. The contract has an ultimate completion date of January 28, 2025 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA...
- This federal contract award, valued at $34,497.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,754.46, is a Firm Fixed Price Delivery Order for the ROTATEQ vaccine in 2 milliliter doses. The contract has an ultimate completion date of December 21, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $3,936.07, is a delivery order to provide the ROTATEQ VACCINE 2ML to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen also holds a separate Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is for the delivery of the ROTATEQ vaccine in 2 milliliter vials. The $3,044.01 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of December 16, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to provide a wide range of...
- This federal contract award, valued at $1,958.62, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the ROTATEQ vaccine, a 2ml dosage. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,304.14, is for the delivery of the rotavirus vaccine ROTATEQ in 2 mL doses. This is a firm fixed-price delivery order contract with an ultimate completion date of October 10, 2024. The contract does not have a set-aside designation. Amerisourcebergen, through its extensive supply chain network, provides...
- The Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $3,639.29 to the Amerisourcebergen Drug Corp Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, through which the company provides a comprehensive range of pharmaceutical products...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,610.05, is for the delivery of the ROTATEQ vaccine in 2-milliliter doses. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award, identified as SPE2DB20D1051|SPE2DB25FD7CW, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,729.31 Firm Fixed Price contract is for the delivery of the ROTATEQ VACCINE 2ML product, with a period of performance through February 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...